Effects of web-based intervention on risk reduction behaviors in melanoma survivors

Journal of Cancer Survivorship

Volumn 9, Issue 2, 2015, Pages 279-286

  Bowen, Deborah J ^a   Burke, Wylie ^a   Hay, Jennifer L ^b   Meischke, Hendrika ^c   Harris, Julie N ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d DIVISION OF RESEARCH   (United States)

Author keywords

Family communication; Melanoma; Prevention; Web based

Indexed keywords

ADULT; AGED; BEHAVIOR THERAPY; CONTROLLED STUDY; FAMILY; FEMALE; HEALTH BEHAVIOR; HUMAN; INTERNET; MALE; MELANOMA; MIDDLE AGED; MORTALITY; NEOPLASMS, SECOND PRIMARY; PARENT; PATHOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SELF EXAMINATION; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA; SURVIVOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BEHAVIOR THERAPY; FAMILY; FEMALE; HEALTH BEHAVIOR; HUMANS; INTERNET; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PARENTS; RISK REDUCTION BEHAVIOR; SELF-EXAMINATION; SKIN NEOPLASMS; SURVIVORS; YOUNG ADULT;

EID: 84929704402     PISSN: 19322259     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-014-0412-0     Document Type: Article

References (38)

1. What are the key statistics about melanoma skin cancer? In: Melanoma Skin Cancer. American CancerSociety 2014; http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics.
2. SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds).
3. ASCO 2011 Abstract: LBA5 Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma. Wolchok JD, Thomas L, Bondarenko IN, O’Day S, Weber JS, Garbe C, Francis S, Ibrahim RA, Hoos A, Robert C.
4. Coyte A, Morrison DS, McLoone P. Second primary cancer risk—the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014. doi:10.1186/1471-2407-14-272.
5. Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004. doi:10.1007/s10552-004-2474-1.
6. Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer. 2012. doi:10.1002/cncr.26707.
7. Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik J, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011. doi:10.1016/j.jaad.2011.04.031.
8. Melanoma Skin Cancer. In Skin Cancer. American Cancer Society. 2013. http://www.cancer.org/acs/groups/cid/documents/webcontent/003120-pdf.pdf. Accessed 2 May 2014.
9. Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013. doi:10.1007/s13671-012-0035-5.
10. Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, et al. Sun protection and skin self-examination in melanoma survivors. Psycho-Oncology. 2009. doi:10.1002/pon.1510.
11. Manne S, Lessin S. Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med. 2006. doi:10.1007/s10865-006-9064-5.
12. Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, et al. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology. 2013. doi:10.1002/pon.2059.
13. Körner A, Drapeau M, Thombs BD, Rosberger Z, Wang B, Khanna M, et al. Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care. BMC Dermatol. 2013. doi:10.1186/1471-5945-13-3.
14. Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, J Lee JE, Gershenwald JE. Randomized Controlled Trial of a Sun Protection Intervention for Children of Melanoma Survivors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2013; doi:10.1158/1055-9965.
15. Geller AC, Emmons KE, Brooks DR, Powers C, Zhang Z, Koh HK, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006. doi:10.1002/cncr.22050.
16. Bowen DJ, Jabson JM, Haddock N, Hay J, Edwards K. Skin care behaviors among melanoma survivors. Psycho-Oncology. 2011. doi:10.1002/pon.2017.
17. Pitceathly C, Maguire P. The psychological impact of cancer on patients’ partners and other key relatives. Eur J Cancer. 2003. doi:10.1016/S0959-8049(03)00309-5.
18. Novilla MLB, Barnes MD, Natalie G, Williams PN, Rogers J. Public health perspectives on the family: an ecological approach to promoting health in the family and community. Family Commun Health. 2006;29(1):28–42.
19. Hay J, Shuk E, Brady MS, Berwick M, Ostroff J, Halpern A. Family communication after melanoma diagnosis. Arch Dermatol. 2008. doi:10.1001/archderm.144.4.553.
20. Geller 23296633 pulls up oliviera reference #13. The paper references #20 with respect to poor communication among family members about family risk.
21. Cappelli M et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychol, Health Med. 2001;6(3):321–33.
22. Friedman LC, Webb JA, Everett TE. Psychosocial and medical predictors of colorectal cancer screening among low-income medical outpatients. J Cancer Educ. 2004;19(3):180–6.
23. McCaul KD et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996;15(6):423–9.
24. Anton-Culver H et al. The cancer genetics network: recruitment results and pilot studies. Commun Genet. 2003;6(3):171–7.
25. Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, et al. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012;33(1):85–92.
26. Bowen DJ, Christensen CL, Powers D, Graves DR, Anderson CAM. Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. J Clin Psychol Med Settings. 1998;5:365–80.
27. Bowen DJ, Burke W, McTiernan A, Powers D, Durfy S, Gralow J, et al. Participation in breast cancer risk counseling among women with a history of cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:581–6. PMID: 1042819.
28. Bowen DJ, Powers D, Greenlee H. Effects of breast cancer risk counseling for sexual minority women. Health Care Women Int. 2005;27:59–74.
29. Bowen DJ, Powers DM. Effects of a mail/telephone intervention on breast health behaviors. Health Educ Behav. 2010;37(4):479–89.
30. Cancer Melanoma. In: Disease Risk Index. Harvard School of Public Health. 2008. http://www.diseaseriskindex.harvard.edu/update/hccpquiz.pl?lang=english&func=home&quiz=melanoma. Accessed 8 May 2014.
31. Weinstock M, Risica P, Martin R, Rakowski W, Dube C, Berwick M, et al. Melanoma early detection with thorough skin self-examination the ‘Check It Out’ randomized trial. Am J Prev Med. 2007. doi:10.1016/j.amepre.2007.02.024.
32. Oh SS, Mayer JA, Lewis EC, Slymen DJ, Sallis JF, Elder JP, et al. Validating outdoor workers’ self-report of sun protection. Prev Med. 2004;39(4):798–803.
33. Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12(4):843–50.
34. Meropol NJ, Daly MB, Vig HS, Manion FJ, Manne SL, Mazar C, et al. Delivery of internet-based cancer genetic counselling services to patients’ homes: a feasibility study. J Telemed Telecare. 2011. doi:10.1258/jtt.2010.100116.
35. Manne S, Jacobsen PB, Ming ME, Winkel W, Dessureault S, Lessin SR. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol: Off J Div Health Psychol, Am Psychol Assoc. 2010. doi:10.1037/a0021387.
36. Kovalyshyn I. The impact of physician screening on melanoma detection. Arch Dermatol. 2011. doi:10.1001/archdermatol.2011.181.
37. Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomark Prev. 2014. doi:10.1158/1055-9965.EPI-13-1085.
38. Torres SM, Ramos M, Leverence R, Bowen D, Berwick M, Hay J. A pilot study of skin cancer risk reduction behaviors, cancer communications, and skin cancer beliefs in Hispanics in a Southwestern primary care practice. Californian Journal of Health Promotion. 12:1; 95–100.